Japan To Introduce New Quality Verification System For Generic Drugs
This article was originally published in PharmAsia News
In an effort to reduce safety concerns about generic drugs and increase generic usage, Japan's Ministry of Health, Labor and Welfare will introduce a third-party verification system, in addition to the ministry's approval review. The new system will verify efficacy, and confirm that generics use the same active ingredients as brand products and contain no impure substances. MHLW has established a study group under the National Institute of Health Science to spearhead the system's implementation; the group's first meeting took place July 10. (Click here for more - Japanese language
You may also be interested in...
TOKYO - Japan's Ministry of Health, Labor and Welfare Nov. 7 listed 99 generic drugs made from 35 composites for National Health Insurance price listing and coverage, according to an official of the ministry's Insurance Bureau Nov. 13
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.